Stout Thomas E, Said Mohammed A, Tracy Chad R, Steinberg Ryan L, Nepple Kenneth G, Gellhaus Paul T
Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Transl Androl Urol. 2023 Oct 31;12(10):1518-1527. doi: 10.21037/tau-23-270. Epub 2023 Oct 11.
Robotic retroperitoneal partial nephrectomy (rRPN) has numerous advantages over transperitoneal surgery, including direct access to the renal hilum and posterior tumors, and avoidance of the peritoneal cavity in patients with a hostile abdomen. Although the use of the retroperitoneal approach has increased over the last decade, there is little literature on robotic retroperitoneal radical nephrectomy (rRRN), which has similar benefits over the transperitoneal approach. The aim of this study was to describe our technique for robotic retroperitoneal nephrectomy (rRN) and assess its feasibility and outcomes at a high-volume center.
A retrospective review of patients who underwent some form of rRN [rRRN, robotic retroperitoneal simple nephrectomy (rRSN), or robotic retroperitoneal nephroureterectomy (rRNU)] at a single institution between 2013 and 2023. Patient characteristics, operative data, and postoperative complication rates were assessed. The technique for rRN was detailed.
A total of 13 renal units in 12 patients were included for analysis (7 rRRN, 5 rRSN, 1 rRNU). Median patient age was 64.0 years, and median body mass index (BMI) was 36.0 kg/m. Indications for retroperitoneal surgery were prior abdominal surgery in all patients, including three with bowel diversions, super morbid central obesity in two patients, and a large ventral hernia in one patient. Median operative time was 213 minutes and median estimated blood loss (EBL) was 85 cc. Median postoperative length of stay (LOS) was 3 days, and only one patient experienced a Clavien-Dindo grade ≥3 complication within 90 days of surgery.
The retroperitoneal approach for robotic-assisted nephrectomy is feasible and associated with similar outcomes as the transperitoneal approach. This approach may prove beneficial in select patients with significant prior abdominal surgery including those who are morbidly obese.
机器人辅助腹膜后肾部分切除术(rRPN)相较于经腹手术具有诸多优势,包括可直接显露肾门和后部肿瘤,以及避免对腹部情况不佳的患者打开腹腔。尽管在过去十年中腹膜后入路的使用有所增加,但关于机器人辅助腹膜后根治性肾切除术(rRRN)的文献却很少,而该手术与经腹入路相比也有类似的优势。本研究的目的是描述我们的机器人辅助腹膜后肾切除术(rRN)技术,并在一个高容量中心评估其可行性和手术效果。
回顾性分析2013年至2023年在单一机构接受某种形式rRN手术(rRRN、机器人辅助腹膜后单纯肾切除术[rRSN]或机器人辅助腹膜后肾输尿管切除术[rRNU])的患者。评估患者特征、手术数据和术后并发症发生率。详细介绍了rRN技术要点。
共纳入12例患者的13个肾单位进行分析(7例rRRN、5例rRSN、1例rRNU)。患者中位年龄为64.0岁,中位体重指数(BMI)为36.0kg/m²。所有患者选择腹膜后手术的指征均为既往有腹部手术史,其中3例患者有肠造口术,2例患者为超级病态中央型肥胖,1例患者有巨大腹疝。中位手术时间为213分钟,中位估计失血量(EBL)为85cc。术后中位住院时间(LOS)为3天,仅有1例患者在术后90天内发生Clavien-Dindo≥3级并发症。
机器人辅助肾切除术的腹膜后入路是可行的,其手术效果与经腹入路相似。对于有显著既往腹部手术史的特定患者,包括病态肥胖患者,这种入路可能是有益的。